Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities:
Net earnings	$ 696.0	$ 480.0	$ 847.7
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	1,805.8	1,523.0	1,032.1
Deferred income tax benefit	(111.4)	(609.5)	(115.9)
Litigation settlements and other contingencies, net	(40.1)	597.7	15.1
Unrealized losses on acquisition-related foreign currency derivatives	0.0	128.6	0.0
Loss from equity method investments	58.0	112.8	105.1
Stock-based compensation expense	74.7	88.9	92.8
Write off of financing fees	3.2	35.8	99.6
Other non-cash items	261.0	499.4	263.2
Changes in operating assets and liabilities:
Accounts receivable	(162.2)	(131.8)	65.8
Inventories	(129.5)	(279.3)	(320.4)
Trade accounts payable	14.4	87.7	131.8
Income taxes	15.2	37.5	(164.2)
Other operating assets and liabilities, net	(420.3)	(523.6)	(44.2)
Net cash provided by operating activities	2,064.8	2,047.2	2,008.5
Cash flows from investing activities:
Cash paid for acquisitions, net	(167.0)	(6,481.9)	(693.1)
Capital expenditures	(275.9)	(390.4)	(362.9)
Payments for product rights and other, net	(620.3)	(360.2)	(506.5)
Cash paid for Meda's unconditional deferred payment	0.0	(308.0)	0.0
Settlement of acquisition-related foreign currency derivatives	0.0	(128.6)	0.0
Proceeds from sale of assets and subsidiaries	86.7	0.0	0.0
Change in restricted cash	71.0	57.1	21.8
Purchase of marketable securities	(96.5)	(30.2)	(62.1)
Proceeds from sale of marketable securities	96.6	21.5	33.1
Net cash used in investing activities	(905.4)	(7,620.7)	(1,569.7)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	876.1	11,752.2	3,539.2
Payment of long-term debt	(2,232.7)	(6,296.3)	(4,484.1)
Payment of financing fees	(10.1)	(112.6)	(130.4)
Proceeds from convertible note hedge	0.0	0.0	1,970.8
Change in short-term borrowings, net	(2.9)	40.8	(329.2)
Purchase of common stock	(500.2)	0.0	(67.5)
Proceeds from exercise of stock options	17.8	13.8	97.7
Taxes paid related to net share settlement of equity awards	(7.4)	(17.5)	(31.8)
Contingent consideration payments	(26.1)	(35.5)	0.0
Acquisition of noncontrolling interest	(7.5)	(1.1)	(11.7)
Other items, net	(0.1)	0.8	51.8
Net cash (used in) provided by financing activities	(1,893.1)	5,344.6	604.8
Effect on cash of changes in exchange rates	27.0	(8.3)	(33.1)
Net (decrease) increase in cash and cash equivalents	(706.7)	(237.2)	1,010.5
Cash and cash equivalents — beginning of period	998.8	1,236.0	225.5
Cash and cash equivalents — end of period	292.1	998.8	1,236.0
Non-cash transactions:
Non-cash transactions		16.0	18.0
Ordinary shares issued for acquisition	0.0	1,281.7	6,305.8
Cash paid during the period for:
Income taxes	285.7	285.6	302.9
Interest	474.0	357.2	254.7
Other current liabilities
Non-cash transactions:
Non-cash transactions	$ 4.0	$ 16.0	$ 18.0